{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:30:33Z","timestamp":1769873433258,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.transproceed.2005.02.118","type":"journal-article","created":{"date-parts":[[2005,4,11]],"date-time":"2005-04-11T16:04:12Z","timestamp":1113235452000},"page":"4-17","source":"Crossref","is-referenced-by-count":36,"special_numbering":"S","title":["Improving outcomes in heart transplantation: The potential of proliferation signal inhibitors"],"prefix":"10.1016","volume":"37","author":[{"given":"H.","family":"Eisen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kobashigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Starling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Valantine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2005.02.118_bib1","unstructured":"Organ Procurement and Transplantation Network reports 1996\u20132001. Available at: www.optn.org. Accessed February 2005"},{"key":"10.1016\/j.transproceed.2005.02.118_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/CVM-1-3-166","article-title":"Review what is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?","volume":"1","author":"Kobashigawa","year":"2000","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"10.1016\/j.transproceed.2005.02.118_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1053-2498(00)00249-7","article-title":"Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study","volume":"20","author":"Jimenez","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1053-2498(03)00186-4","article-title":"The registry of the international society for heart and lung transplantation: twentieth official adult heart transplant report\u20142003","volume":"222","author":"Taylor","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1053-2498(99)00128-X","article-title":"Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging","volume":"19","author":"Kapadia","year":"2000","journal-title":"J Heart Lung Transplant"},{"issue":"suppl","key":"10.1016\/j.transproceed.2005.02.118_bib6","first-page":"S38","article-title":"Histopathology of graft coronary disease","volume":"11","author":"Billingham","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib7","series-title":"Heart Transplantation","first-page":"p 615","article-title":"Cardiac allograft vasculopathy (chronic rejection)","author":"Kirklin","year":"2002"},{"key":"10.1016\/j.transproceed.2005.02.118_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pharmthera.2003.08.002","article-title":"Immunosuppression and transplant vascular disease: benefits and adverse effects","volume":"100","author":"Moien-Ashfari","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2005.02.118_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00001573-200403000-00019","article-title":"Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention and treatment","volume":"19","author":"Pinney","year":"2004","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.transproceed.2005.02.118_bib10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1600-6143.2004.00434.x","article-title":"Immune and non-immune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression","volume":"4","author":"Caforio","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib11","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.healun.2004.03.009","article-title":"Cardiac allograft vasculopathy after heart transplantation: risk factors and management","volume":"23","author":"Valantine","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1067\/mtc.2003.168","article-title":"Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study","volume":"125","author":"Kirklin","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.transproceed.2005.02.118_bib13","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1001\/jama.1989.03420240075030","article-title":"Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis","volume":"261","author":"Grattan","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2005.02.118_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11883-004-0035-4","article-title":"Intravascular ultrasound assessment of atherosclerosis","volume":"6","author":"Guedes","year":"2004","journal-title":"Current Atherosclerosis Reports"},{"key":"10.1016\/j.transproceed.2005.02.118_bib15","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.CIR.98.24.2672","article-title":"Development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis comparison by serial intravascular ultrasound imaging","volume":"98","author":"Kapadia","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2005.02.118_bib16","first-page":"980","article-title":"Prediction of angiographic disease by intracoronary ultrasonographic findings in heart transplant recipients","volume":"15","author":"Liang","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib17","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","article-title":"American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS)","volume":"37","author":"Mintz","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2005.02.118_bib18","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1161\/01.CIR.92.12.3445","article-title":"Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation","volume":"92","author":"Rickenbacker","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2005.02.118_bib19","first-page":"632","article-title":"Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy","volume":"14","author":"Mehra","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1053-2498(03)00210-9","article-title":"First-year intravascular ultrasound results as a surrogate marker for outcomes after heart transplantation","volume":"22","author":"Kobashigawa","year":"2003","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 8","key":"10.1016\/j.transproceed.2005.02.118_bib21","first-page":"549","article-title":"Multi-center intravascular ultrasound validation study among heart transplant recipients: outcomes after 5 years","volume":"4","author":"Kobashigawa","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.118_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1053-2498(03)00097-4","article-title":"Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia","volume":"23","author":"Pethig","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib24","doi-asserted-by":"crossref","unstructured":"Kobashigawa J: Further analysis of the intravascular ultrasound (IVUS) data from the randomized mycophenolate mofetil (MMF) trial in heart transplant recipients. Data presented at the 24th Annual Meeting of the ISHLT, San Francisco, Calif, USA, April 2004","DOI":"10.1016\/j.healun.2003.11.003"},{"key":"10.1016\/j.transproceed.2005.02.118_bib25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/01.TP.0000090393.75600.32","article-title":"Differential effect of cyclosporine A and SDZ RAD on neointima formation of carotid artery allografts in apolipoprotein E-deficient mice","volume":"76","author":"Matsumoto","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.118_bib26","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/S0041-1345(98)00590-9","article-title":"Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model","volume":"30","author":"Cole","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2005.02.118_bib27","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0041-1345(98)01885-5","article-title":"SDZ RAD inhibits cold ischemia-induced vascular remodeling","volume":"31","author":"Schuurman","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2005.02.118_bib28","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1161\/01.CIR.0000065576.80196.A4","article-title":"Sirolimus (rapamycin) monotherapy prevents graft vascular disease in nonhuman primate recipients of orthotopic aortic allografts","volume":"107","author":"Dambrin","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2005.02.118_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","article-title":"Use of rapamycin slows progression of cardiac transplantation vasculopathy","volume":"108","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2005.02.118_bib30","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary heart disease at 2 years","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2005.02.118_bib31","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1016\/j.transproceed.2005.02.118_bib32","first-page":"457","article-title":"Kobashigawa J, Starling RC, Mehra MR, Bhat G, Kormos RL, Barr ML: Impact of ongoing post cardiac transplant risk factors on outcomes: a multi-center study","volume":"3","year":"2003","journal-title":"Am J Transplant"},{"issue":"suppl 5","key":"10.1016\/j.transproceed.2005.02.118_bib33","first-page":"550","article-title":": 24-month results of a multicenter study of Certican for the prevention of allograft rejection and vasculopathy in de novo cardiac transplant recipients","volume":"3","author":"Mancini","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib34","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJM200210173471619","article-title":"Sirolimus eluting coronary stents","volume":"347","author":"Sharma","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2005.02.118_bib35","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2005.02.118_bib36","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000128850.84227.FD","article-title":"Six and twelve month results from first human experience using everolimus eluting stents with bio-absorbable polymer","volume":"109","author":"Grube","year":"2004","journal-title":"Circulation"},{"issue":"suppl 2","key":"10.1016\/j.transproceed.2005.02.118_bib37","first-page":"44","article-title":"Weill D: Role of cytomegalovirus in cardiac allograft vasculopathy","volume":"3","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2005.02.118_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0966-3274(97)80050-0","article-title":"Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients","volume":"5","author":"Toyoda","year":"1997","journal-title":"Transplant Immunology"},{"key":"10.1016\/j.transproceed.2005.02.118_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1600-6143.2003.00316.x","article-title":"The role of viruses in cardiac allograft vasculopathy","volume":"4","author":"Valantine","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib40","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S1053-2498(02)00905-1","article-title":"Everolimus is associated with a reduced incidence of CMV infection in heart transplantation","volume":"22","author":"Dorent","year":"2003","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 5s","key":"10.1016\/j.transproceed.2005.02.118_bib41","first-page":"S202","article-title":"Keogh A: Calcineurin inhibitors in heart transplantation","volume":"23","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-199707150-00007","article-title":"SDZ, a new rapamycin derivative: synergism with cyclosporine","volume":"64","author":"Schuurman","year":"1997","journal-title":"Transplantation"},{"issue":"suppl B","key":"10.1016\/j.transproceed.2005.02.118_bib43","first-page":"B101","article-title":"MacDonald A, Scarola J, Burke JT, Zimmerman JJ: Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus","volume":"22","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.transproceed.2005.02.118_bib44","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1046\/j.1600-6143.2004.00601.x","article-title":"Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure\u2013effect modeling","volume":"4","author":"Starling","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib45","doi-asserted-by":"crossref","unstructured":"Lorber M, Ponticelli C, Whelchel J, et al: Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data. Clin Transplant 19:145, 2005","DOI":"10.1111\/j.1399-0012.2005.00326.x"},{"key":"10.1016\/j.transproceed.2005.02.118_bib46","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2004.00389.x","article-title":"Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies","volume":"4","author":"Vitko","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2005.02.118_bib47","unstructured":"Magee J, Tedesco H, Pascual J, et al: Efficacy and safety of 2 doses of everolimus combined with reduced-dose Neoral in de novo kidney transplant recipients: 12 month analysis. Abstract presented at the American Transplant Congress May 14\u201319, Boston, Mass, USA"},{"key":"10.1016\/j.transproceed.2005.02.118_bib48","doi-asserted-by":"crossref","unstructured":"Lehmkuhl H, Hummel M, Dandel M, Grauhan C, Knossalla C, Hetzer R: Everolimus (Certican) in heart transplantation\u2014early experience. Abstract accepted for presentation at ISHLT congress, Philadelphia, Pa, USA, April 5\u20139, 2005","DOI":"10.1016\/j.healun.2004.12.093"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134505002356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134505002356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T15:11:52Z","timestamp":1586185912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134505002356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0041134505002356"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2005.02.118","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}